Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Assets Average (2020 - 2025)

Goldenwell Biotech filings provide 6 years of Assets Average readings, the most recent being $235852.5 for Q3 2025.

  • On a quarterly basis, Assets Average rose 24.19% to $235852.5 in Q3 2025 year-over-year; TTM through Sep 2025 was $235852.5, a 24.19% increase, with the full-year FY2024 number at $226143.0, down 5.08% from a year prior.
  • Assets Average hit $235852.5 in Q3 2025 for Goldenwell Biotech, up from $221605.0 in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $497511.5 in Q3 2021 to a low of $189636.0 in Q3 2023.
  • Median Assets Average over the past 5 years was $233911.0 (2023), compared with a mean of $278748.5.
  • Biggest five-year swings in Assets Average: skyrocketed 89.7% in 2021 and later crashed 45.68% in 2022.
  • Goldenwell Biotech's Assets Average stood at $473413.0 in 2021, then plummeted by 45.66% to $257238.5 in 2022, then fell by 19.33% to $207513.5 in 2023, then dropped by 2.75% to $201812.0 in 2024, then increased by 16.87% to $235852.5 in 2025.
  • The last three reported values for Assets Average were $235852.5 (Q3 2025), $221605.0 (Q2 2025), and $208053.5 (Q1 2025) per Business Quant data.